文献速递胸部肿瘤放疗

既往存在的影像学间质性肺异常是小细胞肺癌患者胸部放疗后重度放射性肺炎的危险因素

Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy.
PubMed 文献 · Radiat Oncol · 2018-05-02

该研究分析了2015年1月至2015年12月间在上海肺科医院接受胸部调强放疗的95例小细胞肺癌患者,评估既往影像学间质性肺异常(ILAs)与放射性肺炎(RP)的关系。结果显示,15.8%的患者存在ILAs,ILAs阳性患者1年≥2级和≥3级RP发生率均显著高于ILAs阴性患者。多因素分析表明,ILAs和吸烟史(≥40包年)是≥3级RP的显著预测因素。

要点

  • 95例小细胞肺癌患者中,15.8%存在既往影像学间质性肺异常(ILAs)。
  • ILAs阳性患者1年≥2级RP发生率为50.0%,显著高于ILAs阴性患者的23.3%(P=0.017)。
  • ILAs阳性患者1年≥3级RP发生率为35.8%,显著高于ILAs阴性患者的8.9%(P=0.005)。

核心结论

  • 既往影像学间质性肺异常(ILAs)和吸烟史(≥40包年)与小细胞肺癌患者胸部放疗后≥3级放射性肺炎风险增加相关。

研究设计与样本

  • 回顾性分析2015年1月至2015年12月间在上海肺科医院接受胸部调强放疗的95例连续小细胞肺癌患者。
  • ILAs诊断由两名经验丰富的胸部放射科医生基于治疗前高分辨率CT影像 review,包括蜂窝状改变、胸膜下网状阴影、磨玻璃影和牵拉性支气管扩张。
  • 采用单因素和多因素分析评估临床因素、既往影像学ILAs及基于剂量体积直方图的剂量学参数与RP的相关性。

主要发现

  • 15例(15.8%)患者存在既往影像学ILAs。
  • 整个队列1年≥2级和≥3级RP发生率分别为27.1%和12.7%。
  • ILAs阳性患者1年≥2级RP发生率为50.0%,ILAs阴性患者为23.3%(P=0.017)。
  • ILAs阳性患者1年≥3级RP发生率为35.8%,ILAs阴性患者为8.9%(P=0.005)。
  • 多因素分析显示,既往影像学ILAs和吸烟史(≥40包年)是≥3级RP的显著预测因素(P分别为0.023和0.012)。

关键数值与推荐

  • ILAs阳性患者1年≥2级RP发生率为50.0%,ILAs阴性患者为23.3%(P=0.017)。
  • ILAs阳性患者1年≥3级RP发生率为35.8%,ILAs阴性患者为8.9%(P=0.005)。
  • 多因素分析中ILAs预测≥3级RP的P=0.023,吸烟史(≥40包年)预测≥3级RP的P=0.012。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies reported that patients with preexisting radiological interstitial lung abnormalities (ILAs) were more susceptible to developing radiation pneumonitis (RP) after thoracic radiation therapy (TRT). The present study aimed to evaluate the incidence and predictors of RP after TRT in patients with small-cell lung cancer (SCLC) with or without preexisting radiological ILAs. METHODS: A total of 95 consecutive patients with SCLC between January 2015 and December 2015, who were treated with thoracic intensity-modulated radiation therapy at Shanghai Pulmonary Hospital,Tongji University School of Medicine, were analyzed. The diagnosis of ILAs was reviewed by two experienced thoracic radiologists based on the pretreatment high-resolution computed tomography imaging, such as honeycombing, subpleural reticular opacities, ground-glass opacity, and traction bronchiectasis. Univariate and multivariate analyses were used to assess the correlation of clinical factors, preexisting radiological ILAs, and dose-volume histogram-based dosimetric parameters with RP. RESULTS: Fifteen (15.8%) patients had preexisting radiological ILAs. The incidence of ≥ grade 2 and 3 RP at 1 year was 27.1% and 12.7% in the entire cohort, respectively. Preexisting radiological ILAs were associated with an increased risk of ≥grade 2 RP (50.0% in ILAs + vs 23.3% in ILAs-, P = 0.017) and ≥ grade 3 RP (35.8% in ILAs + vs 8.9% in ILAs-, P = 0.005) at 1 year. Preexisting radiological ILAs and smoking history (≥40 pack-years of smoking) were significant predictors of ≥grade 3 RP in multivariate analysis (P = 0.023 and 0.012, respectively). CONCLUSIONS: Preexisting radiological ILAs and smoking history (≥40 pack-years of smoking) are associated with an increased risk of ≥grade 3 RP after TRT in patients with SCLC.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Li F, Zhou Z, Wu A, et al. Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy. Radiat Oncol. 2018. PMID: 29716649. doi:10.1186/s13014-018-1030-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。